Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Nanobiotechnology|January 28, 2025
A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancerXue Zheng, Ying Wang, Huaiyu Duan, et al.
ACS Applied Materials & Interfaces|April 20, 2026
Erianin-Loaded AS1411 Aptamer-Albumin Nanoparticles Enhance Antiesophageal Cancer Efficacy by Inducing FerroptosisJunqi Hou, Hexuan Wang, Xue Zheng, et al.
Journal of Integrative Plant Biology|February 10, 2026
PBS1 in heat-immunity crosstalkYixuan Yang, Junqi Hou, Yuanli Wang, et al.
Biochemical Pharmacology|March 7, 2025
Paeonol enhances a recombinant EGFR-targeted fusion protein-drug conjugate induced antitumor efficacy in esophageal cancerHuaiyu Duan, Yuting Li, Xue Zheng, et al.
Progress in Neurobiology|June 14, 2023
Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington's disease knock-in miceDazhang Bai, Longhong Zhu, Qingqing Jia, et al.
Aging Cell|August 26, 2024
Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington's disease knock-in miceDazhang Bai, Fuyu Deng, Qingqing Jia, et al.
Autophagy|August 16, 2025
Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in miceKaili Ou, Xiang Wang, Mingwei Guo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2024
Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid betaChen Zhang, Qingqing Jia, Longhong Zhu, et al.
Nature Communications|May 27, 2026
Caspase-4 transgenic mice exhibit cytoplasmic TDP-43 accumulation and age-dependent neuropathologyQingqing Jia, Longhong Zhu, Dandan Li, et al.
Plant Communications|June 18, 2026
PUB13-Mediated Degradation of PBS3 Regulates Salicylic Acid Biosynthesis to Coordinate Plant Immunity and Leaf LongevityJinyu He, Wei Li, Yunsheng Yang, et al.
Pageof 1